VASCULAR BIOGENICS LTD (VBLT) Stock Balance Sheet
NASDAQ:VBLT - Nasdaq - IL0011327454 - Common Stock - Currency: USD
| MRQ (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 24.26M | 17.66M | 21.99M | 13.18M | 9.44M | |||
| Marketable Securities | 0.00 | 3.05M | 31.16M | 17.11M | 27.10M | |||
| Receivables | N/A | 102.00K | 465.00K | 320.00K | 630.00K | |||
| Other Current Assets | 284.00K | 1.33M | 1.23M | 1.38M | 610.00K | |||
| Total Current Assets | 24.55M | 22.15M | 54.85M | 31.99M | 37.78M | |||
| Non-Current Assets | ||||||||
| PPE Net | 0.00 | 7.14M | 8.86M | 8.76M | 10.10M | |||
| Other Non-Current Assets | 98.00K | 368.00K | 959.00K | 960.00K | 1.12M | |||
| Total Non-Current Assets | 98.00K | 7.51M | 9.81M | 9.72M | 11.23M | |||
| TOTAL ASSETS | 24.65M | 29.66M | 64.66M | 41.71M | 49.01M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 110.00K | 390.00K | |||
| Accrued Expenses | 3.04M | 5.92M | 4.94M | 4.67M | 4.56M | |||
| Accounts Payable | 718.00K | 808.00K | 4.33M | 1.96M | 3.33M | |||
| Other Current Liabilities | 1.54M | 0.00 | 658.00K | 730.00K | 390.00K | |||
| Total Current Liabilities | 5.30M | 6.73M | 9.93M | 7.46M | 8.67M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 100.00K | |||
| Other Non-Current Liabilities | 108.00K | 477.00K | 2.56M | 3.33M | 4.22M | |||
| Total Non-Current Liabilities | 108.00K | 477.00K | 2.56M | 3.33M | 4.31M | |||
| TOTAL LIABILITIES | 5.41M | 7.21M | 12.48M | 10.79M | 12.98M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -297.89M | -294.38M | -258.95M | -221.75M | -200.02M | |||
| Additional Paid In Capital | 316.95M | 316.65M | 309.36M | 252.56M | 235.97M | |||
| Common Shares | 175.00K | 174.00K | 1.77M | 110.00K | 70.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 70.50M | 69.75M | 69.33M | 48.19M | 35.88M | |||
| Tangible Book Value per Share | 0.27 | 0.32 | 0.75 | 0.64 | 1.00 | |||
| Total Shareholders' Equity | 19.24M | 22.45M | 52.18M | 30.92M | 36.02M | |||
| TOTAL LIABILITIES AND EQUITY | 24.65M | 29.66M | 64.66M | 41.71M | 49.01M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.00 | |||
| Current Ratio | 4.63 | 3.29 | 5.53 | 4.29 | 4.36 | |||
| Return On Assets (ROA) | -64.74% | -108.92% | -46.27% | -58.09% | -39.58% | |||
| Return On Equity (ROE) | -82.94% | -143.89% | -57.34% | -78.36% | -53.86% | |||
All data in USD , ROIC based on taxRate of 0.21